<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04491773</url>
  </required_header>
  <id_info>
    <org_study_id>1516/19</org_study_id>
    <nct_id>NCT04491773</nct_id>
  </id_info>
  <brief_title>Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months</brief_title>
  <official_title>Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days for More Than 6 Months: a Single-centre Prospective-control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the retinal and choriocapillary vascular features in patients under the&#xD;
      effects of Tadalafil 20mg for more than 6 months, using optical coherence tomography&#xD;
      angiography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood&#xD;
      flow to the penis thus promoting the erection.&#xD;
&#xD;
      This drug represents an treatment for erectile dysfunction in patients after radical&#xD;
      prostatectomy.&#xD;
&#xD;
      The optical coherence tomography angiography represents a novel and noninvasive diagnostic&#xD;
      technique that allows a detailed and quantitative analysis of retinal and choriocapillary&#xD;
      vascular features.&#xD;
&#xD;
      The study evaluates the changes in optical coherence tomography angiography features after&#xD;
      the somministration of Tadalafil 20 mg orally for more than 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Actual">May 30, 2020</completion_date>
  <primary_completion_date type="Actual">May 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The measurements of retinal and choriocapillary vessel density in patients undergoing Tadalafil for more than 6 months</measure>
    <time_frame>More than 6 months</time_frame>
    <description>Changes in retinal and choriocapillary vessel density in patients after radical prostatectomy, undergoing Tadalafil 20 mg orally on alternate days for more than 6 months, using optical coherence tomography angiography.&#xD;
The parameters analyzed by optical coherence tomography angiography were: retinal and choriocapillary vessel density</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">54</enrollment>
  <condition>Erectile Dysfunction Following Radical Prostatectomy</condition>
  <arm_group>
    <arm_group_label>Patients undergoing Tadalafil</arm_group_label>
    <description>Patients after radical prostatectomy, undergoing Tadalafil 20 mg orally, on alternative days, for more than 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Healthy controls without previous surgery of radical prostatectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tadalafil 20 MG</intervention_name>
    <description>To study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, for more than 6 months.</description>
    <arm_group_label>Patients undergoing Tadalafil</arm_group_label>
    <other_name>Cialis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participans were older than 45 years with diagnosis of erectile dysfunction due to&#xD;
        surgery of radical prostatectomy. They did not receive previous treatment before Tadalafil.&#xD;
        They did not present any ophthalmological disease, diabetes, heart diseases and&#xD;
        hypertension.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age older than 45 years&#xD;
&#xD;
          -  diagnosis of erectile dysfunction due to surgery of radical prostatectomy&#xD;
&#xD;
          -  treatment-na√Øve with Tadalafil for erectile dysfunction for more than 6 months&#xD;
&#xD;
          -  absence of diabetes, heart diseases, hypertension&#xD;
&#xD;
          -  absence of drug intake&#xD;
&#xD;
          -  absence of vitreoretinal, vascular retinal diseases&#xD;
&#xD;
          -  absence of previous ocular surgery and congenital eye diseases.&#xD;
&#xD;
          -  absence of errors of refraction&#xD;
&#xD;
          -  absence of lens opacities&#xD;
&#xD;
          -  absence of low-quality OCT and OCTA images&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 45 years&#xD;
&#xD;
          -  diagnosis of erectile dysfunction due to other causes&#xD;
&#xD;
          -  previous treatments before Tadalafil for erectile dysfunction&#xD;
&#xD;
          -  presence of diabetes, heart diseases, hypertension&#xD;
&#xD;
          -  drug intake&#xD;
&#xD;
          -  vitreoretinal and vascular retinal diseases&#xD;
&#xD;
          -  previous ocular surgery and congenital eye diseases&#xD;
&#xD;
          -  errors of refraction&#xD;
&#xD;
          -  lens opacities&#xD;
&#xD;
          -  low-quality OCT and OCTA images&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilda Cennamo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Naples &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 25, 2020</study_first_submitted>
  <study_first_submitted_qc>July 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>July 25, 2020</last_update_submitted>
  <last_update_submitted_qc>July 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gilda Cennamo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tadalafil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

